- Filed
- May 15, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 15, 2024 | 119.96M sh |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $249.85K |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $266.54K |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $3.48M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $3.45M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $3.48M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $3.45M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $290.67K |
| Current Assets | Q1 2024 · Dec 31, 2023 | $297.52K |
| Total Assets | Q1 2024 · Mar 31, 2024 | $306.68K |
| Total Assets | Q1 2024 · Dec 31, 2023 | $319.12K |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | $0.00 |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | $0.00 |
| Eps Basic | Q1 2024 · Mar 31, 2024 | $0.00 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | $0.00 |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 119.96M sh |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$285.69K |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | −$2.51M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | −$2.28M |
| Net Income | Q1 2024 · Mar 31, 2023 | −$251.75K |
| Operating Income | Q1 2024 · Mar 31, 2023 | −$224.31K |
| Gross Profit | Q1 2024 · Mar 31, 2023 | $11.12K |
| Cost Of Revenue restated | Q1 2024 · Mar 31, 2023 | $65.12K |